Osaka, Japan

Masahiro Yokota

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 7.6

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Takatsuki, JP (2011 - 2012)
  • Osaka, JP (2013 - 2023)

Company Filing History:


Years Active: 2011-2023

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Masahiro Yokota: Innovator in Pharmaceutical Compounds

Introduction

Masahiro Yokota is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds with therapeutic applications. With a total of 5 patents to his name, Yokota's work has the potential to impact medical treatments significantly.

Latest Patents

Yokota's latest patents include innovative compounds such as saturated-ring-fused dihydropyrimidinone or dihydrotriazinone compounds. These compounds exhibit RORγ antagonist activity and are accompanied by pharmaceutical compositions that utilize these compounds for medical purposes. Another notable patent involves dihydropyrimidin-2-one compounds, which also have defined medical uses. These inventions highlight Yokota's commitment to advancing pharmaceutical science.

Career Highlights

Masahiro Yokota is currently employed at Japan Tobacco Inc., where he continues to explore and develop new pharmaceutical solutions. His work at the company has allowed him to focus on innovative research that bridges the gap between chemistry and medicine.

Collaborations

Yokota collaborates with esteemed colleagues such as Noriyoshi Seki and Makoto Shiozaki. These partnerships enhance the research environment and foster the development of groundbreaking pharmaceutical innovations.

Conclusion

Masahiro Yokota's contributions to the field of pharmaceuticals through his patents and collaborations underscore his role as a key innovator. His work continues to pave the way for advancements in medical treatments and compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…